1989
DOI: 10.1021/jm00127a003
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, cytotoxicity, and antiviral activity of certain 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidine nucleosides related to toyocamycin and sangivamycin

Abstract: A number of 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidine derivatives related to the nucleoside antibiotics toyocamycin and sangivamycin were prepared and tested for their biological activity. Treatment of the sodium salt of 4-amino-6-bromo-5-cyanopyrrolo[2,3-d]pyrimidine (1) with (2-acetoxyethoxy)methyl bromide (2) afforded a mixture of 4-amino-6-bromo-5-cyano-7-[(2-acetoxyethoxy)methyl]pyrrolo[2,3-d] pyrimidine (3) and the corresponding N1 isomer. Debromination of this mixture gave the corresponding 4-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
20
0

Year Published

1989
1989
2016
2016

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 47 publications
(22 citation statements)
references
References 6 publications
2
20
0
Order By: Relevance
“…[31] A mixture of substrate 1 and 2a was heated in refluxing toluene in the presence of BF 3 ·OEt 2 for 12 h. Two products were obtained, that is, 6-(4-chlorophenyl)-1,3,7-trimethylpyrido[3,2-d]pyrimidine-2,4-(1H,3H)-dione (3a, 86 %) along with a small amount of 1,3,6-trimethylpyrrolo[3,2-d]pyrimidine-2,4-(1H,3H)-dione derivative 4 as a side product, which is also potentially bioactive [32,33] (Scheme 1). Compound 4 can also be obtained as a side product during the formation of the starting material from 5-(allylamino)-1,3-dimethylpyrimidine-2,4-(1H,3H)-dione by aza-Claisen rearrangement using BF 3 ·OEt 2 as a catalyst.…”
Section: Resultsmentioning
confidence: 99%
“…[31] A mixture of substrate 1 and 2a was heated in refluxing toluene in the presence of BF 3 ·OEt 2 for 12 h. Two products were obtained, that is, 6-(4-chlorophenyl)-1,3,7-trimethylpyrido[3,2-d]pyrimidine-2,4-(1H,3H)-dione (3a, 86 %) along with a small amount of 1,3,6-trimethylpyrrolo[3,2-d]pyrimidine-2,4-(1H,3H)-dione derivative 4 as a side product, which is also potentially bioactive [32,33] (Scheme 1). Compound 4 can also be obtained as a side product during the formation of the starting material from 5-(allylamino)-1,3-dimethylpyrimidine-2,4-(1H,3H)-dione by aza-Claisen rearrangement using BF 3 ·OEt 2 as a catalyst.…”
Section: Resultsmentioning
confidence: 99%
“…Derivatives closely related to tubercidin, toyocamycin, and sangivamycin were prepared and tested on the same antiviral assays [77][78][79]. Parent compounds 77, 78, and 79 were very active in inhibiting replication of Human CytoMegalo Virus (HCMV), but were also very cytotoxic [77] (Table 9).…”
Section: -Deazapurine Nucleoside Analoguesmentioning
confidence: 99%
“…Seco-ribose (95)(96)(97) and (dihydroxypropoxy)methyl derivatives (98-102) were inactive, except for compound 102, which was as active as ganciclovir and showed no appreciable cytotoxicity [77]. Also, 7[(2-hydroxyethoxy)methyl] derivatives (103-109) showed no antiviral efficacy, except for compound 108, which possessed some activity along with no cytotoxicity [79] (Table 9).…”
Section: -Deazapurine Nucleoside Analoguesmentioning
confidence: 99%
See 1 more Smart Citation
“…ring is a common motif in several natural porducts and biologically active compounds and provide privileged scaffold for the generation of target compound in drug discovery [2][3][4][5]. Pyrido [2,3-d]pyrimidines exhibit diverse biological and pharmacological activities such as antitumor, antipyretic, analgesic, antiallergic, anti-hypertension, bronchitis dilator, strengthen the heart, blood vessel dilator, antimalarial, anti-fungal, adenosine kinase inhibitor, diuretic, tyrosine kinas inhibitors and antibacterial activity [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20].…”
Section: Introductionmentioning
confidence: 99%